We’re excited to announce that Verified Clinical Trials (VCT) will be exhibiting and hosting a special panel discussion focused on the growing challenges of duplicate and professional subjects in vaccine clinical trials.
Vaccine clinical trials present a unique set of challenges, particularly when it comes to subject verification. Unlike many other clinical studies, vaccine trials often require rapid enrollment and same-day randomization and dosing following screening. This accelerated timeline leaves little to no room for traditional duplicate subject checks, increasing the risk of enrolling subjects who may already be participating in the same or another study.
This risk is further heightened in vaccine trials that typically recruit large numbers of healthy volunteers. Without adequate safeguards, studies become vulnerable to professional subjects—individuals who enroll in multiple trials simultaneously or in quick succession—potentially compromising data integrity and participant safety.
Verified Clinical Trials is uniquely positioned to solve these challenges.
VCT offers the only solution capable of detecting duplicate and professional subjects at the time of screening, before they are randomized and dosed. More than just detection, VCT actively prevents these issues, safeguarding both study integrity and participant safety.
As a cross-sponsor, cross-study solution, VCT provides unmatched oversight across multiple trials and research sites. Our system offers global support and includes advanced biometric options, such as fingerprint verification and soon-to-be-released facial biometrics, enhancing both speed and accuracy during screening.
Our panel will dive deep into:
- The specific risks duplicate and professional subjects pose to vaccine trials.
- How the rapid pace of enrollment in vaccine studies amplifies these challenges.
- How VCT’s real-time detection and prevention capabilities set a new standard in trial integrity.
Join us as we explore these critical issues and highlight how Verified Clinical Trials continues to safeguard research while streamlining operations.
Stay tuned for more details on our panel schedule and booth information. We look forward to seeing you there!
